Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,207,680
+$2,620,139 QoQ
Shares Held
62,336
+45.2% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 211 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. ANAB ranks #29 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in ANAB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,207,680 | 62,336 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,587,541 | 28,625 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,670,666 | 55,088 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,588,181 | 378,452 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,179,523 | 368,447 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $306,492 | 16,487 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,130,448 | 85,381 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,543,476 | 46,074 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,182,909 | 47,203 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,112,237 | 49,389 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $763,087 | 35,625 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,713,848 | 206,785 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $4,041,985 | 198,721 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,470,880 | 159,507 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $308,478 | 15,196 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,756,203 | 111,407 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,103,770 | 89,317 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,398,167 | 88,428 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,312,078 | 89,166 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,030,122 | 94,205 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,534,623 | 71,378 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,045,048 | 70,851 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,420,619 | 63,591 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $488,686 | 34,585 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||